IP Library Granted Patent US 8,423,145
Granted Patent B2
US 8,423,145 · App. 13/523,855 · Granted Apr 16, 2013

Differential neurostimulation therapy driven by physiological therapy

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,423,145
App. No.
13/523,855
Granted
Apr 16, 2013
Kind
B2
Abstract

An implantable neurostimulator system adapted to provide therapy for various neurological disorders is capable of varying therapy delivery strategies based on the context, physiological or otherwise, into which the therapy is to be delivered. Responsive and scheduled therapies can be varied depending on various sensor measurements, calculations, inferences, and device states (including elapsed times and times of day) to deliver an appropriate course of therapy under the circumstances.

Claims (38)

1. A method for treating a neurological disorder in a patient, the method comprising the steps of:

implanting a device in the body of the patient;

implanting a plurality of electrodes in the body of the patient, wherein each of the plurality of electrodes is coupled to the device;

detecting, by at least one of a plurality of detection channels, a neurological event of interest in a monitored electrographic signal of a patient, the plurality of detection channels including at least one triggering detection channel that is configured to derive signal timing for delivering a selected therapy when a parameter is detected, the parameter being associated with the triggering detection channel and corresponding to an electrographic measurement, a characteristic of the neurological event of interest being represented by the electrographic measurement;

analyzing the parameter measured by the implantable device;

selecting a therapy from a plurality of therapies based at least in part on the parameter;

determining a timing of the therapy based at least in part on the parameter; and

applying the selected therapy to the patient in synchronization with the neurological event of interest based at least in part on the parameter.

2. The method for treating a neurological disorder of claim 1 , further comprising the step of implanting a sensor in the body of the patient, when wherein the parameter is obtained from the sensor.

3. The method for treating a neurological disorder of claim 2 , wherein the sensor comprises one of: an EEG sensor; an EMG sensor; an accelerometer; a motion sensor; an orientation sensor; a blood pressure sensor; a blood flow sensor; a blood oxygenation sensor; a drug concentration sensor; a neurotransmitter concentration sensor; and a sleep sensor.

4. The method for treating a neurological disorder in a patient of claim 1 , further comprising:

transforming the parameter into a numeric quantity; and

selecting the type of therapy based on the numeric quantity.

5. The method for treating a neurological disorder in a patient of claim 4 , further comprising:

selecting the type of therapy based on a comparison of the numeric quantity to a predetermined range of values.

6. The method for treating a neurological disorder in a patient of claim 4 , wherein the transformed parameter is mapped to a specified distribution.

7. The method for treating a neurological disorder in a patient of claim 1 , further comprising:

modifying the therapy based at least in part on the parameter.

8. The method for treating a neurological disorder in a patient of claim 1 , further comprising:

repeating the analyzing, selecting, determining, and applying steps.

9. The method for treating a neurological disorder in a patient of claim 1 , wherein the type of therapy selected from a plurality of possible therapies comprises an application of electrical brain stimulation.

10. The method for treating a neurological disorder in a patient of claim 9 , wherein the electrical brain stimulation comprises responsive stimulation.

11. The method for treating a neurological disorder in a patient of claim 9 , wherein the electrical brain stimulation comprises programmed stimulation.

12. The method for treating a neurological disorder in a patient of claim 1 , wherein the therapy comprises an application of a therapeutic agent.

13. The method for treating a neurological disorder in a patient of claim 1 , wherein the therapy comprises an application of sensory stimulation.

14. The method for treating a neurological disorder in a patient of claim 1 , wherein the therapy comprises a patient warning.

15. The method for treating a neurological disorder in a patient of claim 1 , wherein the therapy is applied to a focus of epileptic form activity.

16. The method for treating a neurological disorder in a patient of claim 1 , wherein the therapy is applied to a predetermined site in the brain of the patient.

17. The method for treating a neurological disorder in a patient of claim 16 , wherein the predetermined site is located in a target structure selected from a group comprising the caudate nucleus, the subthalamic nucleus, the anterior thalamus, the ventralateral thalamus, the globus pallidus internus, the globus pallidus externus, the substantia nigra, and the neostriatum.

18. The method for treating a neurological disorder in a patient of claim 16 , wherein the predetermined site comprises a functional neural pathway.

19. A method for using an implantable device to treat a neurological disorder, the method comprising:

detecting, by at least one of a plurality of detection channels, a neurological event of interest in a monitored electrographic signal of a patient, the plurality of detection channels including at least one triggering detection channel that is configured to derive signal timing for delivering a selected therapy when a parameter is detected, the parameter being associated with the triggering detection channel and corresponding to an electrographic measurement, a characteristic of the neurological event of interest being represented by the electrographic measurement;

analyzing the parameter measured by the implantable device;

selecting a therapy from a plurality of therapies based at least in part on the parameter;

determining a timing of the therapy based at least in part on the parameter; and

applying the selected therapy to the patient in synchronization with the neurological event of interest based at least in part on the parameter.

20. The method for using an implantable device to treat a neurological disorder of claim 19 , further comprising:

storing the parameter that comprises the electrographic measurement.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2025
From: CRG SERVICING LLC AS SUCCESSOR TO CAPITAL ROYALTY PARTNERS II L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., AND PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEUROPACE INC.
Reel/Frame 071495/0800 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 20, 2014
From: NEUROPACE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034410/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2012
From: PLESS, BENJAMIN D; TCHENG, THOMAS K
To: NEUROPACE, INC.
Reel/Frame 028603/0485 →